ZD Medical
Hangzhou
About ZD Medical
ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both macular degeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $35.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2024)
- Website: zd-med.com
- Phone: 400-166-9973
Industries & Categories
Manufacturing, Medical, Medical Device
Canonical: https://fsome.com/organization/zd-medical-153680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.